YOSHIDA Yataro | Takeda General Hospital
スポンサーリンク
概要
関連著者
-
YOSHIDA Yataro
Takeda General Hospital
-
Taniwaki M
Kyoto Prefectural Univ. Medicine Kyoto
-
Takatoku Masaaki
Department Of Hematology And Oncology Kyoto Prefectural University Of Medicine
-
Teramura M
Department Of Hematology Tokyo Women's Medical University
-
TOHYAMA Kaoru
Department of Laboratory Medicine, Kawasaki Medical School
-
Taniwaki Masafumi
The Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Tohyama K
Department Of Laboratory Medicine Kawasaki Medical School
-
Tohyama Kaoru
Department Of Laboratory Medicine
-
KUROKAWA Mineo
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
NAKAO Shinji
Department of Cellular Transplantation Biology, Graduate School of Medical Sciences, Kanazawa Univer
-
ISHIKAWA Takayuki
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
UCHIYAMA Takashi
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
TANIWAKI Masafumi
Department of Environmental Systems Engineering, Kochi University of Technology
-
TAKESHITA Kenichi
Celgene Corporation
-
TAKATOKU Masaaki
Celgene KK
-
Kimura Akiro
Department of Hematology & Oncology, Research Institute for Radiation Biology and Medicine, Hiroshim
-
NAKAO Shinji
Kanazawa University Hospital
-
TERAMURA Masanao
Department of Hematology, Tokyo Women's Medical University School
-
Ozawa Keiya
Division of Genetic Therapeutics, Jichi Medical School
-
Teramura Masanao
Department Of Hematology Tokyo Women's Medical University
-
Teramura Masanao
Department Of Haematology Tokyo Women's Medical University
-
Sahara Naohi
浜松医科大学 内科学第3
-
Nakamura Satoki
県西部浜松医療センター 血液科
-
Shirafuji Naoki
Department Of Hematology Kanazawa University
-
HARADA Hironori
Department of Hematology and Oncology, Hiroshima University
-
WATANABE Mitsumasa
Osaka Red Cross Hospital
-
SUZUKI Kenshi
Japan Red Cross Medical Center
-
YANAGITA Soshi
Shizuoka General Hospital
-
SUZUKI Takahiro
Division of Hematology, Jichi Medical University
-
TSUDO Mitsuru
Osaka Red Cross Hospital
-
MATSUDA Akira
Department of Hematology, Saitama International Medical Center, Saitama Medical University
-
YOSHIDA Yataro
Department of Hematology, Takeda Ijinkai General Hospital
-
MOTOJI Toshiko
Department of Hematology, Tokyo Women's Medical University
-
OMINE Mitsuhiro
Division of Hematology, Showa University Fujigaoka Hospital
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Ozawa Keiya
Division Of Hematology Jichi Medical University
-
Kimura Akiro
Department Of Environment And Mutation Research Institute For Radiation Biology And Medicine Hiroshi
-
Kimura Akiro
Department Of Hematology And Oncology Hiroshima University
-
Nakao Shinji
Department Of Cellular Transplantation Biology Kanazawa University Graduate School Of Medical Scienc
-
ISHIKAWA Takayuki
Kyoto University
-
OMINE Mitsuhiro
Showa University Fujigaoka Hospital
-
Takeshita Kenichi
Celgene Corp. Summit Usa
-
Ishikawa Takayuki
Department Of Frontier Informatics Graduate School Of Frontier Sciences The University Of Tokyo
-
Kurokawa Mineo
Department Of Hematology And Oncology Graduate School Of Medicine University Of Tokyo
-
Kurokawa Mineo
Department Of Hematology And Oncology University Of Tokyo
-
Nakao Shinji
Third Department Of Medicine Kanazawa University
-
Uchiyama Takashi
Department Of Cardiology Nihon University Nerimahikarigaoka Hospital
-
Motoji Toshiko
Department Of Haematology Tokyo Women's Medical University
-
Taniwaki Masafumi
Department Of Clinical Molecular Genetics And Laboratory Medicine Kyoto Prefectural University Of Me
-
Yoshida Yataro
Department Of Gynecology And Obstetrics And Blood Transfusion Service Faculty Of Medicine. Kyoto Uni
-
Omine M
Showa Univ. Fujogaoka Hospital Yokohama Jpn
-
Omine Mitsuhiro
Division Of Hematology Internal Medicine Showa University Fujigaoka Hospital
-
Harada Hironori
Department Of Hematology And Oncology Hiroshima University
-
Harada Hironori
Department Of Agricultural Chemistry The University Of Tokyo
-
Inamoto Takashi
Department Of Hematology And Oncology Graduate School Of Medicine Kyoto University
-
Saito Toshiki
Division Of Hematology Jichi Medical University
-
YOSHIDA Yataro
Editor-in-Chief,International Journal of Hematology
-
Ozawa Keiya
Division Of Genetic Therapeutics Center For Molecular Medicine Jichi Medical School Crest Japan Scie
-
Mitani Kinuko
Department Of Hematology Dokkyo Medical University
-
Matsuda Akira
Department Of Hematology Saitama International Medical Center Saitama Medical University
-
Matsuda Akira
Department Of Applied Chemistry Ehime University
-
Ozawa Keiya
Division Of Genetic Therapeutics Center For Molecular Medicine Department Of Medicine Jichi Medical
-
Nakamura Satoko
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Uchiyama Takashi
Department Of Hematology And Oncology Kyoto University
-
Kurokawa Mineo
Department Of Hematology And Oncology The University Of Tokyo Hospital
-
Suzuki Takahiro
Division Of Hematology Jichi Medical University
-
Ishikawa Takayuki
Department Of Animal Sciences Nihon University
-
Ozawa Keiya
Division Of Genetic Therapeutics Center For Molecular Medicine
-
Kurokawa Mineo
Department Of Hematology And Oncology Graduate School Of Medicine The University Of Tokyo
-
Suzuki Takahiro
Division Of Hematology Department Of Medicine Jichi Medical University
-
MITANI Kinuko
Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
-
Kurokawa Mineo
Department of Hematology & Oncology, The University of Tokyo
-
Ozawa Keiya
Division of Cell Therapy, Jichi Medical University Hospital, Shimotsuke
-
Suzuki Takahiro
Division of Cell Therapy, Jichi Medical University Hospital, Shimotsuke
著作論文
- Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality
- A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
- Peer Review System : Any Other Choice?
- Evolving New Treatment for Myelodysplastic Syndromes
- The aplasia-myelodysplasia enigma:a re-emerging question
- A Eulogy for Dr. Gyouichi Wakisaka
- Seventh International Symposium on Myelodysplastic Syndromes